NCT07069452 Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke
| NCT ID | NCT07069452 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier de Gonesse |
| Condition | Stroke, Ischemic |
| Study Type | OBSERVATIONAL |
| Enrollment | 152 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2026-01-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 152 participants in total. It began in 2025-04-15 with a primary completion date of 2026-01-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study, called TARGET-ASPECT, looks at patients who had a type of stroke called acute ischemic stroke and were treated with clot-busting medicine and a procedure to remove the clot. Even with these treatments, about half of patients don't fully recover. The study aims to see if certain brain imaging scores, especially when combined, can better predict how well patients will recover 90 days after their stroke and if their blood vessels reopen successfully. The study will include 152 patients and last about 9 months. The goal is to find easy and reliable tools that doctors can use to make better treatment decisions.
Eligibility Criteria
Inclusion Criteria : * Patients aged 18 years or older * Confirmed acute ischemic stroke on imaging * Treated with both thrombolysis and thrombectomy * Clinical follow-up data available at 90 days (mRS score) Exclusion Criteria : * Primary hemorrhagic stroke * Early death or loss to follow-up without evaluation * Poor-quality imaging that cannot be analyzed
Frequently Asked Questions
Who can join the NCT07069452 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke, Ischemic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07069452 currently recruiting?
Yes, NCT07069452 is actively recruiting participants. Visit ClinicalTrials.gov or contact Centre Hospitalier de Gonesse to inquire about joining.
Where is the NCT07069452 trial being conducted?
This trial is being conducted at Gonesse, France.
Who is sponsoring the NCT07069452 clinical trial?
NCT07069452 is sponsored by Centre Hospitalier de Gonesse. The trial plans to enroll 152 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.